Founder and Medical Director of The SerenaGroup®, a group of wound care clinics, Dr. Serena is a vascular surgeon and long-time proponent of hyperbaric oxygen therapy. The internationally recognized expert in the field of wound healing has been the lead or Principal Investigator in over 100 clinical trials. He has a vast knowledge of oxygen therapy and understands its positive impact on chronic wounds.

Dr. Serena has published more than 200 papers and given more than 1,000 lectures worldwide. His well-decorated tenure includes past-President of the Association for the Advancement of Wound Care (AAWC) and the American Professional Wound Care Association, former board member of the Wound Healing Society, and also Vice-President of the American College of Hyperbaric Medicine. He has also developed a diagnostic technique to collect proteases from chronic wounds, called The Serena Technique©.

Dr. Windy Cole holds a bachelor’s degree in biology from the University of Cincinnati and is a graduate of the Kent State University College of Podiatric Medicine. Dr. Cole practices in Northeast Ohio where she serves as Medical Director of the Wound Care Center, University Hospitals Ahuja Medical Center and as Adjunct Professor and Director of Wound Care Research at Kent State University College of Podiatric Medicine. A dedicated wound care advocate for two decades, Dr. Cole is interested in medical education, diabetic foot care, wound care, limb salvage, and clinical research. Her passion to help others has led her to humanitarian efforts, including a medical mission to Jordan in 2018 to aid Syrian refugees. Dr. Cole has published numerous articles and is in demand as a speaker both nationally and internationally. She is a feature writer for Podiatry Management and Today’s Wound Clinic and is a contributing writer for Podiatry Today.

Dr. Wahab is a wound care specialist and serves as medical director for the Mountainview Wound care and Hyperbaric Center, the inpatient medical director for Dignity Health Hospitals in Las Vegas and for Post Acute Medical Hospital in Las Vegas, NV. She is an active member of many wound care organizations. She completed her tenure as a  board member and treasurer for AAWC. She is a member of the European Wound Management Association and currently is a committee member for the Alliance of Wound Care Stakeholders and participates in multiple education committees for wound healing. Dr. Wahab is passionate about research and has her own research department to conduct clinical trials for wound healing.  Dr. Wahab participates on many medical advisory boards for wound care biotech innovations. She is faculty for Roseman University College of Medicine Nevada  and part of the Internal Medicine GME program for Mountainview Hospital. Dr. Wahab utilizes a research-oriented multidisciplinary approach to foster a personalized environment for her patients by integrating new technological advancements in her patient centered wound therapy programs.

Dr. Schultz is Professor Emeritus at the University of Florida where he served as Director of the Institute for Wound Research and Professor of Obstetrics and Gynecology. His extensive research primarily focuses on the regulators of normal wound healing and understanding the role bacterial biofilms and proteases play in impairing wound healing.  Dr Schultz has authored or co-authored over 400 publications that have been cited over 23,000 times.  He has received $38 million in grant support as a principal- or co-investigator, is an inventor on 36 patents, and was elected a Fellow of the National Academy of Inventors.  He served as President of the Wound Healing Society and served on the National Pressure Injury Advisory Panel.

His research focuses on the molecular and cellular regulation of wound healing, and covers the spectrum of wound repair from normal healing to the pathological conditions of excessive healing (fibrosis) and failed healing (chronic wounds). Schultz’s lab was the first to recognize the dramatic differences in the molecular environments of acute and chronic wounds. These basic science discoveries have translated into improved clinical treatments embodied in the concepts of “Wound Bed Preparation” and “Biofilm Based Wound Care.”

Schultz has received numerous recognitions for his research and teaching, including Medicinae Doctorem (honoris causa) from the University of Linköping, Sweden, TIME magazine Innovation Leader, Silver Fellow of the Association for Research in Vision and Ophthalmology and President of the Wound Healing Society.

Founder and Medical Director of The SerenaGroup®, a group of wound care clinics, Dr. Serena is a vascular surgeon and long-time proponent of hyperbaric oxygen therapy. The internationally recognized expert in the field of wound healing has been the lead or Principal Investigator in over 100 clinical trials. He has a vast knowledge of oxygen therapy and understands its positive impact on chronic wounds.

Dr. Serena has published more than 200 papers and given more than 1,000 lectures worldwide. His well-decorated tenure includes past-President of the Association for the Advancement of Wound Care (AAWC) and the American Professional Wound Care Association, former board member of the Wound Healing Society, and also Vice-President of the American College of Hyperbaric Medicine. He has also developed a diagnostic technique to collect proteases from chronic wounds, called The Serena Technique©.

Dr. Windy Cole holds a bachelor’s degree in biology from the University of Cincinnati and is a graduate of the Kent State University College of Podiatric Medicine. Dr. Cole practices in Northeast Ohio where she serves as Medical Director of the Wound Care Center, University Hospitals Ahuja Medical Center and as Adjunct Professor and Director of Wound Care Research at Kent State University College of Podiatric Medicine. A dedicated wound care advocate for two decades, Dr. Cole is interested in medical education, diabetic foot care, wound care, limb salvage, and clinical research. Her passion to help others has led her to humanitarian efforts, including a medical mission to Jordan in 2018 to aid Syrian refugees. Dr. Cole has published numerous articles and is in demand as a speaker both nationally and internationally. She is a feature writer for Podiatry Management and Today’s Wound Clinic and is a contributing writer for Podiatry Today.

Dr. Wahab is a wound care specialist and serves as medical director for the Mountainview Wound care and Hyperbaric Center, the inpatient medical director for Dignity Health Hospitals in Las Vegas and for Post Acute Medical Hospital in Las Vegas, NV. She is an active member of many wound care organizations. She completed her tenure as a  board member and treasurer for AAWC. She is a member of the European Wound Management Association and currently is a committee member for the Alliance of Wound Care Stakeholders and participates in multiple education committees for wound healing. Dr. Wahab is passionate about research and has her own research department to conduct clinical trials for wound healing.  Dr. Wahab participates on many medical advisory boards for wound care biotech innovations. She is faculty for Roseman University College of Medicine Nevada  and part of the Internal Medicine GME program for Mountainview Hospital. Dr. Wahab utilizes a research-oriented multidisciplinary approach to foster a personalized environment for her patients by integrating new technological advancements in her patient centered wound therapy programs.

Dr. Schultz is Professor Emeritus at the University of Florida where he served as Director of the Institute for Wound Research and Professor of Obstetrics and Gynecology. His extensive research primarily focuses on the regulators of normal wound healing and understanding the role bacterial biofilms and proteases play in impairing wound healing.  Dr Schultz has authored or co-authored over 400 publications that have been cited over 23,000 times.  He has received $38 million in grant support as a principal- or co-investigator, is an inventor on 36 patents, and was elected a Fellow of the National Academy of Inventors.  He served as President of the Wound Healing Society and served on the National Pressure Injury Advisory Panel.

His research focuses on the molecular and cellular regulation of wound healing, and covers the spectrum of wound repair from normal healing to the pathological conditions of excessive healing (fibrosis) and failed healing (chronic wounds). Schultz’s lab was the first to recognize the dramatic differences in the molecular environments of acute and chronic wounds. These basic science discoveries have translated into improved clinical treatments embodied in the concepts of “Wound Bed Preparation” and “Biofilm Based Wound Care.”

Schultz has received numerous recognitions for his research and teaching, including Medicinae Doctorem (honoris causa) from the University of Linköping, Sweden, TIME magazine Innovation Leader, Silver Fellow of the Association for Research in Vision and Ophthalmology and President of the Wound Healing Society.